Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Rochester |
---|---|
Information provided by: | University of Rochester |
ClinicalTrials.gov Identifier: | NCT00243269 |
This study hypothesizes that patients receiving efficacy enhancing information about the acupressure bands will expect less treatment-related nausea, which will subsequently result in less treatment-related nausea compared to patients who do not receive such information.
This study extends prior research by utilizing a randomized controlled trial in a clinical environment to examine the efficacy of an intervention that is specifically designed to reduce patients’ response expectancies concerning nausea development from cancer treatments, and, thereby, reduce nausea.
The objectives of this study are as follow:
To provide preliminary data on whether a two-tiered strategy to increase patients’ expectancies for nausea prevention and/or management is more effective than a single-tiered strategy in reducing chemotherapy- induced nausea.
Condition | Intervention | Phase |
---|---|---|
Nausea |
Behavioral: Acupressure expectancy enhancement |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Placebo Control, Single Group Assignment, Efficacy Study |
Official Title: | Acupressure and Relaxation for Nausea Control |
Estimated Enrollment: | 67 |
Study Start Date: | November 2005 |
This study hypothesizes that patients receiving efficacy enhancing information about the acupressure bands will expect less treatment-related nausea, which will subsequently result in less treatment-related nausea compared to patients who do not receive such information.
This study extends prior research by utilizing a randomized controlled trial in a clinical environment to examine the efficacy of an intervention that is specifically designed to reduce patients’ response expectancies concerning nausea development from cancer treatments, and, thereby, reduce nausea.
The objectives of this study are as follow:
To provide preliminary data on whether a two-tiered strategy to increase patients’ expectancies for nausea prevention and/or management is more effective than a single-tiered strategy in reducing chemotherapy- induced nausea.
The study contains the following arms:
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contact: Leslie Gillies | 585-275-0690 | leslie_gillies@urmc.rochester.edu |
United States, New York | |
University of Rochester James P. Wilmot Cancer Center | Recruiting |
Rochester, New York, United States, 14642 |
Principal Investigator: | Joseph A Roscoe, PhD | University of Rochester |
Study ID Numbers: | U2905 |
Study First Received: | October 19, 2005 |
Last Updated: | October 13, 2006 |
ClinicalTrials.gov Identifier: | NCT00243269 History of Changes |
Health Authority: | United States: Institutional Review Board |
Arm 1 = control handout and control tape Arm 2 = active handout and control tape Arm 3 = control handout and active tape Arm 4 = active handout and active tape) |
Signs and Symptoms Signs and Symptoms, Digestive Nausea |
Signs and Symptoms Signs and Symptoms, Digestive Nausea |